SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001773427-24-000008
Filing Date
2024-02-27
Accepted
2024-02-27 06:44:27
Documents
16
Period of Report
2024-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K swtx-20240227.htm   iXBRL 8-K 29472
2 EX-99.1 q42023-earningsrelease.htm EX-99.1 71101
6 GRAPHIC springworkslogojpeg.jpg GRAPHIC 8674
  Complete submission text file 0001773427-24-000008.txt   250080

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT swtx-20240227.xsd EX-101.SCH 1907
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT swtx-20240227_lab.xml EX-101.LAB 23806
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT swtx-20240227_pre.xml EX-101.PRE 12512
17 EXTRACTED XBRL INSTANCE DOCUMENT swtx-20240227_htm.xml XML 2929
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 24681862
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)